Does the media favor CTSH or DOX?

In the previous week, Cognizant Technology Solutions had 15 more articles in the media than Amdocs. MarketBeat recorded 19 mentions for Cognizant Technology Solutions and 4 mentions for Amdocs. Cognizant Technology Solutions' average media sentiment score of 0.96 beat Amdocs' score of 0.68 indicating that Cognizant Technology Solutions is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cognizant Technology Solutions 12 Very Positive mention(s) 4 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Amdocs 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better earnings and valuation, SSNC or DOX?

SS&C Technologies has higher revenue and earnings than Amdocs. Amdocs is trading at a lower price-to-earnings ratio than SS&C Technologies, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio SS&C Technologies $6.27B 2.61 $796.90M $3.23 21.01 Amdocs $4.53B 1.25 $564.70M $5.00 10.49

Is SSNC or DOX more profitable?

SS&C Technologies has a net margin of 12.65% compared to Amdocs' net margin of 11.81%. SS&C Technologies' return on equity of 20.15% beat Amdocs' return on equity. Company Net Margins Return on Equity Return on Assets SS&C Technologies 12.65% 20.15% 7.05% Amdocs 11.81% 19.77% 10.87%

Does the media favor SSNC or DOX?

In the previous week, SS&C Technologies had 16 more articles in the media than Amdocs. MarketBeat recorded 20 mentions for SS&C Technologies and 4 mentions for Amdocs. SS&C Technologies' average media sentiment score of 0.68 beat Amdocs' score of 0.68 indicating that SS&C Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SS&C Technologies 8 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Amdocs 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better valuation & earnings, ACN or DOX?

Accenture has higher revenue and earnings than Amdocs. Amdocs is trading at a lower price-to-earnings ratio than Accenture, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Accenture $69.67B 1.36 $7.68B $12.52 11.37 Amdocs $4.53B 1.25 $564.70M $5.00 10.49

Is ACN or DOX more profitable?

Amdocs has a net margin of 11.81% compared to Accenture's net margin of 10.66%. Accenture's return on equity of 26.47% beat Amdocs' return on equity. Company Net Margins Return on Equity Return on Assets Accenture 10.66% 26.47% 12.89% Amdocs 11.81% 19.77% 10.87%

Does the media favor ACN or DOX?

In the previous week, Accenture had 32 more articles in the media than Amdocs. MarketBeat recorded 36 mentions for Accenture and 4 mentions for Amdocs. Accenture's average media sentiment score of 1.23 beat Amdocs' score of 0.68 indicating that Accenture is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Accenture 27 Very Positive mention(s) 3 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Amdocs 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable earnings and valuation, LDOS or DOX?

Leidos has higher revenue and earnings than Amdocs. Leidos is trading at a lower price-to-earnings ratio than Amdocs, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Leidos $17.17B 0.77 $1.45B $10.92 9.62 Amdocs $4.53B 1.25 $564.70M $5.00 10.49

Is LDOS or DOX more profitable?

Amdocs has a net margin of 11.81% compared to Leidos' net margin of 8.15%. Leidos' return on equity of 31.92% beat Amdocs' return on equity. Company Net Margins Return on Equity Return on Assets Leidos 8.15% 31.92% 11.23% Amdocs 11.81% 19.77% 10.87%

Does the media prefer LDOS or DOX?

In the previous week, Leidos had 6 more articles in the media than Amdocs. MarketBeat recorded 10 mentions for Leidos and 4 mentions for Amdocs. Leidos' average media sentiment score of 0.79 beat Amdocs' score of 0.68 indicating that Leidos is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Leidos 7 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Amdocs 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor CACI or DOX?

In the previous week, CACI International had 4 more articles in the media than Amdocs. MarketBeat recorded 8 mentions for CACI International and 4 mentions for Amdocs. CACI International's average media sentiment score of 0.86 beat Amdocs' score of 0.68 indicating that CACI International is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CACI International 5 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Amdocs 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Amdocs (DOX) Competitors

$52.45 -0.74 (-1.39%)

As of 11:42 AM Eastern

Compare

DOX vs. CTSH, SSNC, ACN, LDOS, and CACI

Should you buy Amdocs stock or one of its competitors? MarketBeat compares Amdocs with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Amdocs include Cognizant Technology Solutions (CTSH), SS&C Technologies (SSNC), Accenture (ACN), Leidos (LDOS), and CACI International (CACI). These companies are all part of the "computer and technology" sector.

How does Amdocs compare to Cognizant Technology Solutions?

Cognizant Technology Solutions (NASDAQ:CTSH) and Amdocs (NASDAQ:DOX) are both computer and technology companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, risk, analyst recommendations, profitability, media sentiment, dividends, earnings and valuation.

Cognizant Technology Solutions pays an annual dividend of $1.32 per share and has a dividend yield of 3.0%. Amdocs pays an annual dividend of $2.28 per share and has a dividend yield of 4.3%. Cognizant Technology Solutions pays out 28.7% of its earnings in the form of a dividend. Amdocs pays out 45.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cognizant Technology Solutions has raised its dividend for 6 consecutive years and Amdocs has raised its dividend for 14 consecutive years. Amdocs is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Cognizant Technology Solutions has a beta of 0.87, suggesting that its stock price is 13% less volatile than the broader market. Comparatively, Amdocs has a beta of 0.41, suggesting that its stock price is 59% less volatile than the broader market.

Cognizant Technology Solutions currently has a consensus price target of $64.26, indicating a potential upside of 46.25%. Amdocs has a consensus price target of $86.67, indicating a potential upside of 65.24%. Given Amdocs' higher possible upside, analysts clearly believe Amdocs is more favorable than Cognizant Technology Solutions.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cognizant Technology Solutions	0 Sell rating(s)	14 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.42
Amdocs	1 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.29

92.4% of Cognizant Technology Solutions shares are owned by institutional investors. Comparatively, 92.0% of Amdocs shares are owned by institutional investors. 0.4% of Cognizant Technology Solutions shares are owned by company insiders. Comparatively, 15.4% of Amdocs shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, Cognizant Technology Solutions had 15 more articles in the media than Amdocs. MarketBeat recorded 19 mentions for Cognizant Technology Solutions and 4 mentions for Amdocs. Cognizant Technology Solutions' average media sentiment score of 0.96 beat Amdocs' score of 0.68 indicating that Cognizant Technology Solutions is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cognizant Technology Solutions	12 Very Positive mention(s)	4 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Amdocs	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Amdocs has a net margin of 11.81% compared to Cognizant Technology Solutions' net margin of 10.41%. Amdocs' return on equity of 19.77% beat Cognizant Technology Solutions' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cognizant Technology Solutions	10.41%	17.50%	12.94%
Amdocs	11.81%	19.77%	10.87%

Cognizant Technology Solutions has higher revenue and earnings than Amdocs. Cognizant Technology Solutions is trading at a lower price-to-earnings ratio than Amdocs, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cognizant Technology Solutions	$21.11B	0.99	$2.23B	$4.60	9.55
Amdocs	$4.53B	1.25	$564.70M	$5.00	10.49

Summary

Cognizant Technology Solutions beats Amdocs on 10 of the 19 factors compared between the two stocks.

How does Amdocs compare to SS&C Technologies?

SS&C Technologies (NASDAQ:SSNC) and Amdocs (NASDAQ:DOX) are both computer and technology companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, profitability, institutional ownership, valuation, risk, dividends and media sentiment.

SS&C Technologies pays an annual dividend of $1.08 per share and has a dividend yield of 1.6%. Amdocs pays an annual dividend of $2.28 per share and has a dividend yield of 4.3%. SS&C Technologies pays out 33.4% of its earnings in the form of a dividend. Amdocs pays out 45.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. SS&C Technologies has raised its dividend for 9 consecutive years and Amdocs has raised its dividend for 14 consecutive years. Amdocs is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

SS&C Technologies currently has a consensus target price of $94.13, suggesting a potential upside of 38.69%. Amdocs has a consensus target price of $86.67, suggesting a potential upside of 65.24%. Given Amdocs' higher probable upside, analysts clearly believe Amdocs is more favorable than SS&C Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SS&C Technologies	0 Sell rating(s)	3 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.78
Amdocs	1 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.29

96.9% of SS&C Technologies shares are owned by institutional investors. Comparatively, 92.0% of Amdocs shares are owned by institutional investors. 16.0% of SS&C Technologies shares are owned by company insiders. Comparatively, 15.4% of Amdocs shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, SS&C Technologies had 16 more articles in the media than Amdocs. MarketBeat recorded 20 mentions for SS&C Technologies and 4 mentions for Amdocs. SS&C Technologies' average media sentiment score of 0.68 beat Amdocs' score of 0.68 indicating that SS&C Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
SS&C Technologies	8 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
Amdocs	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

SS&C Technologies has a net margin of 12.65% compared to Amdocs' net margin of 11.81%. SS&C Technologies' return on equity of 20.15% beat Amdocs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SS&C Technologies	12.65%	20.15%	7.05%
Amdocs	11.81%	19.77%	10.87%

SS&C Technologies has a beta of 1.11, indicating that its stock price is 11% more volatile than the broader market. Comparatively, Amdocs has a beta of 0.41, indicating that its stock price is 59% less volatile than the broader market.

SS&C Technologies has higher revenue and earnings than Amdocs. Amdocs is trading at a lower price-to-earnings ratio than SS&C Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SS&C Technologies	$6.27B	2.61	$796.90M	$3.23	21.01
Amdocs	$4.53B	1.25	$564.70M	$5.00	10.49

Summary

SS&C Technologies beats Amdocs on 15 of the 20 factors compared between the two stocks.

How does Amdocs compare to Accenture?

Accenture (NYSE:ACN) and Amdocs (NASDAQ:DOX) are both computer and technology companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, dividends, media sentiment, institutional ownership, profitability, valuation and earnings.

Accenture has higher revenue and earnings than Amdocs. Amdocs is trading at a lower price-to-earnings ratio than Accenture, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Accenture	$69.67B	1.36	$7.68B	$12.52	11.37
Amdocs	$4.53B	1.25	$564.70M	$5.00	10.49

Accenture has a beta of 1.13, indicating that its stock price is 13% more volatile than the broader market. Comparatively, Amdocs has a beta of 0.41, indicating that its stock price is 59% less volatile than the broader market.

In the previous week, Accenture had 32 more articles in the media than Amdocs. MarketBeat recorded 36 mentions for Accenture and 4 mentions for Amdocs. Accenture's average media sentiment score of 1.23 beat Amdocs' score of 0.68 indicating that Accenture is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Accenture	27 Very Positive mention(s)	3 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Amdocs	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Accenture pays an annual dividend of $6.52 per share and has a dividend yield of 4.6%. Amdocs pays an annual dividend of $2.28 per share and has a dividend yield of 4.3%. Accenture pays out 52.1% of its earnings in the form of a dividend. Amdocs pays out 45.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Accenture has raised its dividend for 20 consecutive years and Amdocs has raised its dividend for 14 consecutive years. Accenture is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Accenture currently has a consensus target price of $192.96, suggesting a potential upside of 35.53%. Amdocs has a consensus target price of $86.67, suggesting a potential upside of 65.24%. Given Amdocs' higher possible upside, analysts plainly believe Amdocs is more favorable than Accenture.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Accenture	1 Sell rating(s)	14 Hold rating(s)	12 Buy rating(s)	0 Strong Buy rating(s)	2.41
Amdocs	1 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.29

Amdocs has a net margin of 11.81% compared to Accenture's net margin of 10.66%. Accenture's return on equity of 26.47% beat Amdocs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Accenture	10.66%	26.47%	12.89%
Amdocs	11.81%	19.77%	10.87%

75.1% of Accenture shares are held by institutional investors. Comparatively, 92.0% of Amdocs shares are held by institutional investors. 0.0% of Accenture shares are held by insiders. Comparatively, 15.4% of Amdocs shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Accenture beats Amdocs on 14 of the 19 factors compared between the two stocks.

How does Amdocs compare to Leidos?

Leidos (NYSE:LDOS) and Amdocs (NASDAQ:DOX) are both computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, media sentiment, risk, earnings, dividends, valuation, profitability and analyst recommendations.

In the previous week, Leidos had 6 more articles in the media than Amdocs. MarketBeat recorded 10 mentions for Leidos and 4 mentions for Amdocs. Leidos' average media sentiment score of 0.79 beat Amdocs' score of 0.68 indicating that Leidos is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Leidos	7 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Amdocs	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Leidos has a beta of 0.54, suggesting that its stock price is 46% less volatile than the broader market. Comparatively, Amdocs has a beta of 0.41, suggesting that its stock price is 59% less volatile than the broader market.

Leidos pays an annual dividend of $1.72 per share and has a dividend yield of 1.6%. Amdocs pays an annual dividend of $2.28 per share and has a dividend yield of 4.3%. Leidos pays out 15.8% of its earnings in the form of a dividend. Amdocs pays out 45.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Leidos has raised its dividend for 6 consecutive years and Amdocs has raised its dividend for 14 consecutive years. Amdocs is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Leidos has higher revenue and earnings than Amdocs. Leidos is trading at a lower price-to-earnings ratio than Amdocs, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Leidos	$17.17B	0.77	$1.45B	$10.92	9.62
Amdocs	$4.53B	1.25	$564.70M	$5.00	10.49

Amdocs has a net margin of 11.81% compared to Leidos' net margin of 8.15%. Leidos' return on equity of 31.92% beat Amdocs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Leidos	8.15%	31.92%	11.23%
Amdocs	11.81%	19.77%	10.87%

Leidos presently has a consensus target price of $163.80, indicating a potential upside of 55.93%. Amdocs has a consensus target price of $86.67, indicating a potential upside of 65.24%. Given Amdocs' higher possible upside, analysts clearly believe Amdocs is more favorable than Leidos.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Leidos	0 Sell rating(s)	10 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.47
Amdocs	1 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.29

76.1% of Leidos shares are owned by institutional investors. Comparatively, 92.0% of Amdocs shares are owned by institutional investors. 0.8% of Leidos shares are owned by insiders. Comparatively, 15.4% of Amdocs shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Leidos beats Amdocs on 12 of the 20 factors compared between the two stocks.

How does Amdocs compare to CACI International?

CACI International (NYSE:CACI) and Amdocs (NASDAQ:DOX) are both mid-cap computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their profitability, institutional ownership, valuation, risk, analyst recommendations, media sentiment, earnings and dividends.

Amdocs has a net margin of 11.81% compared to CACI International's net margin of 5.86%. Amdocs' return on equity of 19.77% beat CACI International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CACI International	5.86%	15.90%	6.86%
Amdocs	11.81%	19.77%	10.87%

CACI International has a beta of 0.54, indicating that its stock price is 46% less volatile than the broader market. Comparatively, Amdocs has a beta of 0.41, indicating that its stock price is 59% less volatile than the broader market.

86.4% of CACI International shares are held by institutional investors. Comparatively, 92.0% of Amdocs shares are held by institutional investors. 1.1% of CACI International shares are held by company insiders. Comparatively, 15.4% of Amdocs shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, CACI International had 4 more articles in the media than Amdocs. MarketBeat recorded 8 mentions for CACI International and 4 mentions for Amdocs. CACI International's average media sentiment score of 0.86 beat Amdocs' score of 0.68 indicating that CACI International is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CACI International	5 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Amdocs	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

CACI International presently has a consensus target price of $609.09, indicating a potential upside of 36.07%. Amdocs has a consensus target price of $86.67, indicating a potential upside of 65.24%. Given Amdocs' higher probable upside, analysts plainly believe Amdocs is more favorable than CACI International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CACI International	0 Sell rating(s)	5 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.69
Amdocs	1 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.29

Amdocs has lower revenue, but higher earnings than CACI International. Amdocs is trading at a lower price-to-earnings ratio than CACI International, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CACI International	$8.63B	1.15	$499.83M	$24.24	18.47
Amdocs	$4.53B	1.25	$564.70M	$5.00	10.49

Summary

CACI International beats Amdocs on 9 of the 17 factors compared between the two stocks.

Get Amdocs News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DOX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

DOX vs. The Competition

Export

Metric	Amdocs	IT Services Industry	Computer Sector	NASDAQ Exchange
Market Cap	$5.66B	$12.09B	$38.17B	$12.40B
Dividend Yield	4.32%	2.72%	3.15%	9.39%
P/E Ratio	10.49	45.35	77.76	24.12
Price / Sales	1.25	6.18	597.67	92.58
Price / Cash	6.72	22.36	43.51	47.25
Price / Book	1.71	3.13	9.36	6.23
Net Income	$564.70M	$522.20M	$1.07B	$331.53M
7 Day Performance	0.94%	-2.89%	-1.52%	-1.30%
1 Month Performance	1.90%	-1.11%	-1.29%	-1.40%
1 Year Performance	-40.42%	-24.30%	137.27%	18.15%

Amdocs Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
DOX Amdocs	4.8668 of 5 stars	$52.45 -1.4%	$86.67 +65.2%	-40.5%	$5.66B	$4.53B	10.49	26,969
CTSH Cognizant Technology Solutions	4.9436 of 5 stars	$43.40 +2.3%	$68.35 +57.5%	-41.0%	$20.57B	$21.41B	9.43	351,600
SSNC SS&C Technologies	4.8994 of 5 stars	$66.73 +2.0%	$96.13 +44.1%	-16.7%	$16.07B	$6.27B	20.66	28,800	News Coverage Upcoming Earnings Analyst Forecast Options Volume
ACN Accenture	4.9096 of 5 stars	$138.93 +1.3%	$193.33 +39.2%	-48.8%	$92.78B	$73.10B	11.10	779,000	Positive News Analyst Forecast Gap Down
LDOS Leidos	4.8369 of 5 stars	$106.93 -0.2%	$167.69 +56.8%	-34.2%	$13.45B	$17.17B	9.79	47,000	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:DOX) was last updated on 7/21/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Amdocs (DOX) Competitors

DOX vs. CTSH, SSNC, ACN, LDOS, and CACI

How does Amdocs compare to Cognizant Technology Solutions?

Summary

How does Amdocs compare to SS&C Technologies?

Summary

How does Amdocs compare to Accenture?

Summary

How does Amdocs compare to Leidos?

Summary

How does Amdocs compare to CACI International?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DOX vs. The Competition

Amdocs Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Amdocs (DOX) Competitors

DOX vs. CTSH, SSNC, ACN, LDOS, and CACI

How does Amdocs compare to Cognizant Technology Solutions?

Is CTSH or DOX a better dividend stock?

Which has more volatility and risk, CTSH or DOX?

Do analysts prefer CTSH or DOX?

Do insiders & institutionals believe in CTSH or DOX?

Does the media favor CTSH or DOX?

Is CTSH or DOX more profitable?

Which has stronger valuation and earnings, CTSH or DOX?

Summary

How does Amdocs compare to SS&C Technologies?

Is SSNC or DOX a better dividend stock?

Do analysts rate SSNC or DOX?

Do insiders & institutionals have more ownership in SSNC or DOX?

Does the media favor SSNC or DOX?

Is SSNC or DOX more profitable?

Which has more risk and volatility, SSNC or DOX?

Which has better earnings and valuation, SSNC or DOX?

Summary

How does Amdocs compare to Accenture?

Which has better valuation & earnings, ACN or DOX?

Which has more risk and volatility, ACN or DOX?

Does the media favor ACN or DOX?

Is ACN or DOX a better dividend stock?

Do analysts prefer ACN or DOX?

Is ACN or DOX more profitable?

Do institutionals & insiders have more ownership in ACN or DOX?

Summary

How does Amdocs compare to Leidos?

Does the media prefer LDOS or DOX?

Which has more risk and volatility, LDOS or DOX?

Is LDOS or DOX a better dividend stock?

Which has preferable earnings and valuation, LDOS or DOX?

Is LDOS or DOX more profitable?

Do analysts recommend LDOS or DOX?

Do insiders and institutionals hold more shares of LDOS or DOX?

Summary

How does Amdocs compare to CACI International?

Is CACI or DOX more profitable?

Which has more risk & volatility, CACI or DOX?

Do insiders & institutionals believe in CACI or DOX?

Does the media favor CACI or DOX?

Do analysts prefer CACI or DOX?

Which has preferable earnings & valuation, CACI or DOX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DOX vs. The Competition

Amdocs Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools